This bill, known as the AADAPT Act, would expand the Project ECHO Grant Program to include public and nonprofit private entities in addition to existing eligible organizations. The legislation specifically adds dementia care to the list of health areas the program can support, alongside palliative care. By broadening eligibility and scope, the bill aims to increase the number of healthcare providers trained to address Alzheimer's disease and other forms of dementia. The changes would be implemented through amendments to the Public Health Service Act, allowing for greater knowledge sharing and capacity building in dementia care across the healthcare system.
This bill creates a federal loan forgiveness program to encourage mental health professionals to work in areas with shortages of care providers. It directly affects students and graduates enrolled in mental health training programs at minority-serving institutions who agree to work full-time in underserved communities for at least five years. Under the program, eligible individuals would receive loan deferment during their service period, and after completing five years of employment, the government would repay up to $200,000 of their outstanding student loans. The bill defines qualified mental health providers to include psychiatrists, psychologists, social workers, and other licensed professionals specializing in mental and behavioral health care.
The Promoting Dental Health Act extends federal funding for oral health programs through 2031, directly supporting community dental health initiatives and disease prevention efforts. The bill updates the authorization periods for two specific programs under the Public Health Service Act, shifting coverage from previous years to the 2027-2031 timeframe. This reauthorization allows continued government support for oral health promotion activities without requiring new legislation to maintain existing funding streams.
This bill, titled the Expanding Support for Living Donors Act of 2026, amends the Public Health Service Act to expand financial assistance for individuals who donate organs while alive. It directly affects living organ donors by removing income restrictions and increasing the maximum reimbursement amount for their qualifying medical expenses. The legislation sets a new maximum reimbursement of $10,000 for fiscal year 2027, with automatic annual adjustments based on inflation, and requires the Secretary of Health and Human Services to submit detailed annual reports on program funding, participation, and outcomes. Additionally, the bill mandates a Government Accountability Office study to examine how Medicare could potentially cover costs currently reimbursed through this program.
The Maternal Vaccinations Act aims to increase vaccination rates among pregnant and postpartum individuals by expanding federal health programs. The bill amends the Public Health Service Act to include pregnant and postpartum people in existing vaccination awareness campaigns and adds new funding of $17 million annually from 2027 to 2031 for these efforts. It also requires health programs to specifically target racial and ethnic minority groups within this population to improve access and equity. These changes apply to federal health initiatives administered under the Public Health Service Act.
This bill, known as the PREDICT Act, directs the federal government to provide funding to states, tribes, and local health departments for wastewater surveillance programs designed to detect and monitor infectious diseases. The legislation requires the Secretary of Health and Human Services to award grants and contracts to eligible entities that submit detailed plans for wastewater sampling, data sharing, and response strategies. Funds can be used to establish new testing capabilities, expand surveillance in rural areas and facilities without proper wastewater treatment, and implement evidence-based monitoring practices. The bill also mandates the creation of technical assistance programs and standardized testing guidelines to ensure consistent data collection and reporting across all participating jurisdictions.
This bill, titled the Medicines for the People Act, would create a new National Institute for Biomedical Research and Development within the Public Health Service Act. The new institute would conduct full-cycle research and development of drugs, devices, and biological products using federal laboratories, contracts with public and private entities, and acquisitions of existing technologies. Key provisions include government ownership of patents and trade secrets from institute-funded research, mandatory sharing of clinical trial data with the public, and licensing agreements that prioritize nonprofit and public entities while allowing some for-profit licensing under public interest terms. The institute would be overseen by a 15-member governing board with restrictions on members from the pharmaceutical industry, and it would receive an initial authorization of $90 billion for fiscal year 2027.
This bill creates a temporary exemption process under the Endangered Species Act for water projects meeting "critical human water needs," such as municipal drinking water, firefighting, public health, or food security. Water management agencies (federal, state, or local) must first exhaust conservation measures and alternative water sources before seeking an exemption. Exemptions last up to 180 days and require monthly reports on water use, alternative development efforts, and species impacts, with annual reports to Congress. The Secretary of the Interior must issue implementing regulations within 180 days of enactment. This directly affects water agencies managing critical infrastructure during shortages while maintaining ESA protections through strict conditions and oversight.
The Cannabinoid Safety and Regulation Act establishes federal safety standards for cannabinoid products sold in the United States. It requires manufacturers to register facilities, adhere to strict labeling requirements (including clear THC content and health warnings), and conduct safety testing for contaminants like pesticides and heavy metals. The bill sets serving size limits (capping THC at 5mg per serving for most products) and prohibits certain flavored vape products. It also creates public health initiatives for underage cannabis use prevention and establishes research on cannabis-impaired driving, with funding for state programs to address this issue. The bill directly affects manufacturers, distributors, and retailers of cannabinoid products, bringing them under FDA regulatory oversight.
The Elijah E. Cummings Family Asthma Act authorizes $70 million over five years (2025-2029) to expand the CDC’s National Asthma Control Program. It requires the CDC to collaborate with state health departments to develop state asthma control plans, collect and publish annual data on asthma hospitalizations, emergency visits, and mortality rates disaggregated by race, ethnicity, age, and sex, and identify disparities affecting Black Americans, Native individuals, Puerto Ricans, and low-income populations. The law mandates biennial congressional reports with recommendations to reduce asthma-related hospitalizations, mortality, and economic costs, including strategies to improve care access and address environmental triggers. This bill focuses on enhancing public health surveillance and targeted interventions to reduce asthma’s burden, particularly for disproportionately impacted communities.
